Blues Plans, California Move to Manufacture Generic Drugs

An earlier version of this article incorrectly stated that all Blue Cross Blue Shield affiliates joined a partnership with Civica Rx. As of Feb. 17, 18 Blues plans had joined the agreement. This version has been corrected.

The high price of prescription drugs has frustrated payers for years. Recently, that frustration has led some insurers to enter the drug production business — and states could follow their lead.

0 Comments
© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

cms-website
February 23

Panelists: CMS Prior Authorization Rule Should Help, But More Is Needed

READ MORE
blue-cross-blue-shield-image
February 23

Checking on the Blues: Analysts Predict Margin Uptick in ’23 Will Be Short-Lived

READ MORE
techy-illustration
February 23

ONC Head Touts Interoperability Wins, Poses AI Questions

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today